Can the FDA Salvage Interchangeable Follow-On Biologics?
November 19, 2019
Ted Mathias and Stacie Ropka, PhD
BioProcess Online / Biosimilar Development
BioProcess Online and Biosimilar Development published "Can the FDA Salvage Interchangeable Follow-On Biologics?", an article co-written by Axinn partners Ted Mathias and Stacie Ropka.